Polaryx Therapeutics Inc (PLYX)

$2.40 -0.01 (-0.41%)
Market Cap 113.34M
Revenue (ttm) 0.00
Net Income (ttm) -8.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 44,300
Avg Vol 239,866
Day's Range N/A - N/A
Shares Out 47.03M
Stochastic %K 57%
Beta N/A
Analysts Strong Sell
Price Target $10.00

Company Profile

Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage n...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 940 7236
Website: polaryx.com
Address:
South Tower, 140 E Ridgewood Avenue Suite 415, Paramus, United States
BecauseOfScout
BecauseOfScout Jun. 11 at 5:58 PM
$PLYX Investors at $4 — sure I’m in
0 · Reply
Deelam
Deelam Jun. 11 at 4:09 PM
$PLYX Still no curl. Wild. It's like another $ADTX situation.
0 · Reply
TheOrangeBall
TheOrangeBall Jun. 11 at 3:46 PM
$PLYX 📈
0 · Reply
NVDAMillionaire
NVDAMillionaire Jun. 10 at 3:29 PM
$PLYX Outstanding article that hits the mark on PLYX's current state. So if you want to refresh your PLYX insights or learn about PLYX from scratch, this is a must read. https://everyticker.com/quote/PLYX/analysis/polaryx-therapeutics-a-170m-binary-bet-on-rare-disease-data-at-the-edge-of-a-cash-cliff-nasdaq-plyx
0 · Reply
MurrayK
MurrayK Jun. 9 at 3:42 PM
$PLYX as predicted…you can set your watch to this stock. Each new low is 14-15% below the previous low. A bounce follows then a new low is set in the following weeks.
1 · Reply
Deelam
Deelam Jun. 9 at 3:41 PM
$PLYX Wild. Not sure why support is knocked out of this one. Dilution risk is gone, or at least deferred.
0 · Reply
Abujad1
Abujad1 Jun. 5 at 10:51 PM
$PLYX will see next week above 3$
0 · Reply
MurrayK
MurrayK Jun. 5 at 2:23 PM
$PLYX Here we go again. Probably see this dump another 10-12% today
1 · Reply
MurrayK
MurrayK Jun. 2 at 8:40 PM
$PLYX nice recovery at the end. Let’s hope this continues
0 · Reply
MurrayK
MurrayK Jun. 2 at 5:17 PM
$PLYX past month there have been 4 clear legs down with this being the 4th. Each leg down has been almost exactly 14% lower than the previous low. Almost a perfect repeated leg down each time. Let’s see where this one takes us.
0 · Reply
Latest News on PLYX
Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial

May 28, 2026, 8:30 AM EDT - 4 weeks ago

Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial

Polaryx Therapeutics Quarterly report: Q1 2026

May 15, 2026, 7:00 AM EDT - 5 weeks ago

Polaryx Therapeutics Quarterly report: Q1 2026

Polaryx Therapeutics Receives GHP Magazine's Healthcare & Pharmaceuticals Awards

May 14, 2026, 9:15 AM EDT - 6 weeks ago

Polaryx Therapeutics Receives GHP Magazine's Healthcare & Pharmaceuticals Awards

Polaryx Therapeutics Slides: Corporate presentation

May 8, 2026, 7:00 AM EDT - 6 weeks ago

Polaryx Therapeutics Slides: Corporate presentation

Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference

Apr 23, 2026, 8:30 AM EDT - 2 months ago

Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference

Polaryx receives U.S. FDA Fast Track Designation for PLX-200

2026-04-21T12:59:55.000Z - 2 months ago

Polaryx receives U.S. FDA Fast Track Designation for PLX-200

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

Apr 21, 2026, 8:30 AM EDT - 2 months ago

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care

Apr 15, 2026, 9:15 AM EDT - 2 months ago

Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care

Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference

Apr 1, 2026, 8:30 AM EDT - 3 months ago

Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference

Polaryx Therapeutics Annual report: Q4 2025

Mar 24, 2026, 8:00 AM EDT - 3 months ago

Polaryx Therapeutics Annual report: Q4 2025

Polaryx’s PLX-200 granted FDA Fast Track Designation in LINCL/CLN2

2026-03-17T12:51:50.000Z - 3 months ago

Polaryx’s PLX-200 granted FDA Fast Track Designation in LINCL/CLN2

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)

Mar 17, 2026, 8:30 AM EDT - 3 months ago

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)

Polaryx Therapeutics, Inc trading resumes

2026-03-12T15:10:39.000Z - 3 months ago

Polaryx Therapeutics, Inc trading resumes

Polaryx Therapeutics, Inc trading halted, volatility trading pause

2026-03-12T15:05:41.000Z - 3 months ago

Polaryx Therapeutics, Inc trading halted, volatility trading pause

Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events

Mar 12, 2026, 8:30 AM EDT - 3 months ago

Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events

Polaryx Therapeutics Slides: Corporate presentation

Mar 6, 2026, 6:00 AM EST - 3 months ago

Polaryx Therapeutics Slides: Corporate presentation

Maxim starts Polaryx at Buy, sees PLX-200 as differentiated

2026-02-27T14:09:23.000Z - 4 months ago

Maxim starts Polaryx at Buy, sees PLX-200 as differentiated

Polaryx commits to patients with rare pediatric lysosomal storage disorders

2026-02-27T13:43:18.000Z - 4 months ago

Polaryx commits to patients with rare pediatric lysosomal storage disorders

Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders

Feb 27, 2026, 8:30 AM EST - 4 months ago

Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders

Polaryx initiated with a Buy at Maxim

2026-02-27T13:15:01.000Z - 4 months ago

Polaryx initiated with a Buy at Maxim

Polaryx selects CRO for Soteria Phase 2 trial

2026-02-17T13:35:43.000Z - 4 months ago

Polaryx selects CRO for Soteria Phase 2 trial

Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial

Feb 17, 2026, 8:30 AM EST - 4 months ago

Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial

Polaryx announces pre-clinical data related to Soteria

2026-02-10T13:35:26.000Z - 4 months ago

Polaryx announces pre-clinical data related to Soteria

Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™

Feb 10, 2026, 8:30 AM EST - 4 months ago

Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™

Polaryx Therapeutics, Inc. trading resumes

2026-02-06T15:20:14.000Z - 4 months ago

Polaryx Therapeutics, Inc. trading resumes

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

2026-02-06T15:10:13.000Z - 4 months ago

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

Polaryx Therapeutics, Inc. trading resumes

2026-02-05T20:35:14.000Z - 4 months ago

Polaryx Therapeutics, Inc. trading resumes

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

2026-02-05T20:30:16.000Z - 4 months ago

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

Polaryx appoints Mitchel Berger, Francis Braun, Charles Ryan to board

2026-02-05T13:45:44.000Z - 5 months ago

Polaryx appoints Mitchel Berger, Francis Braun, Charles Ryan to board

Polaryx Therapeutics Welcomes New Members of the Board of Directors

Feb 5, 2026, 8:30 AM EST - 5 months ago

Polaryx Therapeutics Welcomes New Members of the Board of Directors

Polaryx Therapeutics, Inc. trading resumes

2026-02-04T15:05:33.000Z - 5 months ago

Polaryx Therapeutics, Inc. trading resumes

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

2026-02-04T14:55:29.000Z - 5 months ago

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

Polaryx Therapeutics, Inc. trading resumes

2026-02-03T15:20:11.000Z - 5 months ago

Polaryx Therapeutics, Inc. trading resumes

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

2026-02-03T15:10:27.000Z - 5 months ago

Polaryx Therapeutics, Inc. trading halted, volatility trading pause

Polaryx to present late-breaker data related to Soteria ahead of trial

2026-02-03T13:40:26.000Z - 5 months ago

Polaryx to present late-breaker data related to Soteria ahead of trial

Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch

Feb 3, 2026, 8:30 AM EST - 5 months ago

Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch

Polaryx announces direct listing on Nasdaq

2026-02-02T13:51:16.000Z - 5 months ago

Polaryx announces direct listing on Nasdaq

Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”

Feb 2, 2026, 8:30 AM EST - 5 months ago

Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”

Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq

Jan 30, 2026, 8:00 AM EST - 5 months ago

Polaryx Therapeutics Announces Approval to List Common Stock on Nasdaq

BecauseOfScout
BecauseOfScout Jun. 11 at 5:58 PM
$PLYX Investors at $4 — sure I’m in
0 · Reply
Deelam
Deelam Jun. 11 at 4:09 PM
$PLYX Still no curl. Wild. It's like another $ADTX situation.
0 · Reply
TheOrangeBall
TheOrangeBall Jun. 11 at 3:46 PM
$PLYX 📈
0 · Reply
NVDAMillionaire
NVDAMillionaire Jun. 10 at 3:29 PM
$PLYX Outstanding article that hits the mark on PLYX's current state. So if you want to refresh your PLYX insights or learn about PLYX from scratch, this is a must read. https://everyticker.com/quote/PLYX/analysis/polaryx-therapeutics-a-170m-binary-bet-on-rare-disease-data-at-the-edge-of-a-cash-cliff-nasdaq-plyx
0 · Reply
MurrayK
MurrayK Jun. 9 at 3:42 PM
$PLYX as predicted…you can set your watch to this stock. Each new low is 14-15% below the previous low. A bounce follows then a new low is set in the following weeks.
1 · Reply
Deelam
Deelam Jun. 9 at 3:41 PM
$PLYX Wild. Not sure why support is knocked out of this one. Dilution risk is gone, or at least deferred.
0 · Reply
Abujad1
Abujad1 Jun. 5 at 10:51 PM
$PLYX will see next week above 3$
0 · Reply
MurrayK
MurrayK Jun. 5 at 2:23 PM
$PLYX Here we go again. Probably see this dump another 10-12% today
1 · Reply
MurrayK
MurrayK Jun. 2 at 8:40 PM
$PLYX nice recovery at the end. Let’s hope this continues
0 · Reply
MurrayK
MurrayK Jun. 2 at 5:17 PM
$PLYX past month there have been 4 clear legs down with this being the 4th. Each leg down has been almost exactly 14% lower than the previous low. Almost a perfect repeated leg down each time. Let’s see where this one takes us.
0 · Reply
Deelam
Deelam Jun. 2 at 5:04 PM
$PLYX another oof owie today. Hoping they're just setting up a big buyer. 😬
1 · Reply
MurrayK
MurrayK Jun. 1 at 5:52 PM
$PLYX if this follows the trend of last couple of months it’ll hit $2 or lower this week or next. Always finds a lower low after each pump.
1 · Reply
History101
History101 Jun. 1 at 1:28 AM
$PLYX 332 watching 5/31/2026
0 · Reply
alert716
alert716 May. 29 at 5:12 PM
$CDT Over 100% beast mode 🤑🤑🤑🤑 follow for free alerts $PRZO $MASK.X $RDGT $PLYX
0 · Reply
alert716
alert716 May. 29 at 4:23 PM
win after wins ,check my page out guys 🤑🤑🤑 $CDT $CMND $PLYX $MASK.X
2 · Reply
alert716
alert716 May. 29 at 2:32 PM
$PLYX indeed 🤑🤑🤑
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures May. 29 at 2:05 AM
$PLYX CEO purchased 88,453 shares at $4.07 for a total of $360,004. Yang Alex Keun Mo now owns 24,233,249 shares. https://ceo-buys.com
0 · Reply
alert716
alert716 May. 29 at 1:45 AM
$PLYX another winner, it did exactly what I said !! Follow for free daily alerts 🤑🤑🤑 $EDHL $PMAX $GNS $CDT
1 · Reply
alert716
alert716 May. 28 at 5:12 PM
$PLYX great day team 🤑🤑🤑🤑, we also got $MASK.X over 140%
0 · Reply
alert716
alert716 May. 28 at 4:56 PM
$PLYX There you go $3+ 🤑🤑🤑 $MASK.X $DXF
1 · Reply
alert716
alert716 May. 28 at 3:20 PM
$PLYX volume will come in, we made over 100% on $MASK.X
0 · Reply
alert716
alert716 May. 28 at 2:55 PM
$MASK Congrat team if you made over 90% , dont miss $PLYX 🤑🤑🤑🤑
0 · Reply